Breast Cancer Awareness Month

AddLife 26/10/2023

Breast cancer is the most common cancer among women in Sweden. Approximately 20 women are diagnosed every day. Breast cancer treatments have significantly improved over the past twenty years as a result of advances in medical research, technology and understanding of the disease. Today, the five-year survival rate is close to 90 percent, compared to around 75 percent in the 1990s. We've come a long way, but we have further to go.

Breast Cancer Research V2

October marks Breast Cancer Awareness Month and is a good opportunity to reflect and share some insights from our AddLife Group companies.  

Our Biomedical and Research and Diagnostics companies build partnerships with world leading global companies who are consistently pushing the boundaries in innovation that help advance cancer treatments. Here are a few examples:

Next generation sequencing: Accessibility to next generation sequencing has transformed genomics and has made a huge impact on access to personalised cancer treatments along with preventative care. @triolab and @Euroclone are active in this expansive area.

Periostin is a prognostic biomarker in breast cancer. @bionordika DK distributes market leading antibodies for detection of Periostin within cancer reseach

Our team at @Biomedica have developed the ELISA assay kit, to measure human serum periostin levels which aids breast cancer diagnosis, prognosis, and treatment decisions.

News from AddLife’s subsidiaries

Uppsala 2025 Till Linkedin
26 March 2025
Supporting active Ukrainian military medics

Yesterday, AddLife took part in a significant initiative alongside Repower, Region Uppsala, and Akademiska sjukhuset in Uppsala. The project aimed to support active Ukrainian military medics by helping them prevent complex psychological disorders, regain strength, and restore motivation for continued service.

AddLife
MBA Helps With Recovery Of A Deforested Area 2025
21 March 2025
International Day of Forests with MBA SURGICAL EMPOWERMENT

Today we join the celebration of the International Day of Forests, remembering the state of our Bosques MBA SURGICAL EMPOWERMENT project. Since 2022, in collaboration with Bosquia, we have developed an initiative that has allowed us to plant: 🌲 500 trees in 2022 in Niembro (Asturias). 🌲 600 trees in 2023 in Miraflores (Madrid) and Maçanet de la Selva (Girona). 🌲 400 trees in 2024 in Vouzela (Viseu, Portugal). In addition to environmental compensation, this project reinforces the corporate commitment to sustainability and promotes collaborative work between our teams and their families.

MBA